BPG is committed to discovery and dissemination of knowledge
Articles in Press
3/3/2026 7:08:15 AM | Browse: 13 | Download: 0
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Leucine-rich α-2-glycoprotein in Taiwanese inflammatory bowel disease: Strengths and limitations of a novel serum marker
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Rupa Guha and Aditi Banerjee |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Aditi Banerjee, Associate Professor, Department of Pediatrics, University of Maryland School of Medicine, 655 West Baltimore Street, Baltimore, MD 21201, United States. aditi.banerjee@som.umaryland.edu |
| Key Words |
Leucine-rich α2 glycoprotein; Inflammatory bowel disease; Ulcerative colitis; Crohn’s disease; Endoscopic activity; Serum biomarker; Fecal calprotectin |
| Core Tip |
Leucine-rich α-2-glycoprotein (LRG) is an emerging serum biomarker that showed modest but incremental value for predicting endoscopic activity in Taiwanese patients with ulcerative colitis and Crohn’s disease, particularly when combined with C-reactive protein, hemoglobin, and albumin. This Letter highlights methodological issues and clinical implications of LRG testing, including its lower accuracy than fecal calprotectin, single-center data, and lack of standardized cutoffs, and argues that future multicenter, multi-ethnic studies should position LRG within composite biomarker panels and stepwise algorithms for noninvasive assessment of inflammatory bowel disease activity. |
| Citation |
Guha R, Banerjee A. Leucine-rich α-2-glycoprotein in Taiwanese inflammatory bowel disease: Strengths and limitations of a novel serum marker. World J Gastroenterol 2026; In press |
 |
Received |
|
2025-12-11 01:25 |
 |
Peer-Review Started |
|
2025-12-11 01:25 |
 |
First Decision by Editorial Office Director |
|
2026-01-23 09:24 |
 |
Return for Revision |
|
2026-01-23 09:24 |
 |
Revised |
|
2026-02-02 03:48 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-03-03 02:40 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-03-03 07:08 |
 |
Articles in Press |
|
2026-03-03 07:08 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345